Edition:
United Kingdom

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

136JPY
21 Feb 2019
Change (% chg)

¥3 (+2.26%)
Prev Close
¥133
Open
¥136
Day's High
¥139
Day's Low
¥134
Volume
2,742,300
Avg. Vol
1,445,092
52-wk High
¥227
52-wk Low
¥108

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 223.42 -2.396
Sep 11.00 -6.088
Jun 13.45 -4.401
FY 2018 Mar '18 8.07 -4.790
Dec 1.78 -5.302
Sep 0.49 -5.434
Jun 200.92 -3.865
FY 2017 Mar '17 51.88 -5.462
Dec 200.40 -4.773
Sep 33.99 -4.982
Jun 0.39 -5.202
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 2.17 1.08 0.90
Price to Sales (TTM) 76.66 49.51 6.29
Price to Book (MRQ) 3.93 10.14 5.26
Price to Tangible Book (MRQ) 3.93 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg 0.00 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 50,894.16 206.17 12.76
Sales (TTM) vs TTM 1 Yr. Ago 697.90 48.79 5.84
Sales - 5 Yr. Growth Rate -45.97 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 25.70 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 6.91 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -27.64 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 33.72 2.24 2.25
Current Ratio (MRQ) 33.77 3.50 3.08
LT Debt to Equity (MRQ) 0.00 18.65 11.38
Total Debt to Equity (MRQ) 0.00 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -559.44 -- --
EBITD - 5 Yr. Avg -218.73 -110.40 12.87
Operating Margin (TTM) -572.21 -184.63 6.19
Operating Margin - 5 Yr. Avg. -214.42 -126.89 8.31
Pre-Tax Margin (TTM) -575.06 -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -213.47 -132.68 8.61
Net Profit Margin (TTM) -575.86 -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -211.05 -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,022,037 7,654,569 842,388,426
Net Income/Employee (TTM) -51,953,872 562,108 99,841,620
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.04 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -24.64 6.39 11.06
Return on Assets - 5 Yr. Avg. -16.46 5.47 12.20
Return on Investment (TTM) -25.32 8.92 14.45
Return on Investment - 5 Yr. Avg. -17.27 6.78 15.87
Return on Equity (TTM) -25.67 10.08 15.96
Return on Equity - 5 Yr. Avg. -17.58 8.32 17.00
  1 Year 3 Year 5 Year
Sales % 7.40 -34.45 -45.97
EPS (TTM) % -7.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoTherapy Science Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.28 0.38 99 99
13 Week -3.42 -8.01 87 95
26 Week 8.09 -4.56 99 98
52 Week -16.17 -32.73 77 72
YTD -5.58 -15.01 77 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.94%
# of Holders: 9
Total Shares Held: 1,393,233
3 Mo. Net Change: -679,200
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.